Bitcoin.com
March 6, 2026 9:30 AM UTC

Coinbase CEO Brian Armstrong’s Newlimit Raises $435 Million, Tripling Valuation to $3.1 Billion

Newlimit, the longevity biotech co-founded by Coinbase CEO Brian Armstrong, has raised $435 million in a Series C round led by Founders Fund, roughly tripling the company’s valuation to about $3.1 billion. Crypto Wealth Flows Into Longevity Science Newlimit, the anti-aging biotech co-founded by Coinbase Global Inc. (Nasdaq: COIN) Chief Executive Brian Armstrong, has closed

ChartModo Newsletter
Read the Disclaimer : All content available on ChartModo.com, including linked websites, applications, tools, charts, forums, blogs, social media channels, and related platforms (collectively, the “Site”), is provided solely for general informational and educational purposes. Users are expected to conduct their own research, analysis, verification, and due diligence before making financial or investment decisions. Trading and investing involve substantial risk and may result in significant losses. You should consult qualified financial or legal professionals before acting on any information obtained from ChartModo. No content on the Site is intended to constitute a solicitation, recommendation, or offer to buy or sell any security, cryptocurrency, or financial instrument.